Brown Brothers Harriman & Co. »

Mirum Pharmaceuticals shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 1.2k 29.52
2023-09-30 $38k 1.2k 31.60
2023-06-30 $31k 1.2k 25.87

More positions owned by Brown Brothers Harriman & Co.

Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Linde Common Stock (LIN)
Mastercard Inc - A Common Stock (MA)
Zoetis Common Stock (ZTS)
Waste Management Common Stock (WM)
Oracle Corp Common Stock (ORCL)
Kla Corp Common Stock (KLAC)
Progressive Corp Common Stock (PGR)
Arthur J Gallagher & Co Common Stock (AJG)
Alcon Common Stock (ALC)
Amazon.com Common Stock (AMZN)
Booking Holdings Common Stock (BKNG)
Thermo Fisher Scientific Common Stock (TMO)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals